U.S. Intravenous Solutions Market Size, Share and Analysis 2034
U.S. Intravenous Solutions Market Growth, Size, Trends Analysis - By Product, By Nutrients, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Aug-2025 | Report ID: HLCA25255 | Pages: 1 - 145 | Formats*: |
| Category : Healthcare | |||
U.S Intravenous Solutions Market Introduction and Overview
According to SPER Market Research, the U.S Intravenous Solutions Market is estimated to reach USD 11.39 billion by 2034 with a CAGR of 8.05%.
The report includes an in-depth analysis of the U.S. Intravenous Solutions Market, including market size and trends, product mix, Applications, and supplier analysis. The intravenous solutions market in the United States was valued at USD 5.25 billion in 2024 and was expected to increase at a compound annual growth rate (CAGR) of 8.05% between 2025 and 2034. This market expansion is fueled by an aging demographic requiring medical interventions, an increase in chronic illnesses that necessitate advanced treatments, and improvements in healthcare technology that enhance patient care. The growth of this sector underscores the urgent demand for innovative healthcare solutions to meet the intricate challenges of contemporary medicine.
By Product Insights:
The market is separated into two segments: peripheral parenteral nutrition (PPN) and total parenteral nutrition (TPN). In 2024, TPN had the largest share and is projected to grow the fastest. TPN involves delivering all nutrients directly into the bloodstream through an IV, commonly used in surgical intensive care units (ICUs), where over 5 million patients are admitted yearly in the U. S. PPN is also expected to grow significantly as it provides essential nutrients for patients who cannot eat normally, particularly for those with short-term needs, as it is administered through peripheral veins, lowering complications linked to central venous catheters.
By Nutrients Insights:
Regarding nutrient type, single-dose amino acid solutions led the market in 2024, offering a complete protein source that can be customized with other parenteral formulations. The vitamins and minerals segment, including electrolytes, is anticipated to grow rapidly, as vitamins are vital for forming red blood cells and preventing various deficiencies that can lead to serious health conditions.
By End User Insights:
In 2024, hospitals held the largest share of IV solutions due to their essential role in patient care, especially for hydration, medication delivery, and nutritional support. The high number of patients needing treatments like chemotherapy and surgery recovery requires a steady supply of IV solutions. The home segment is expected to grow the fastest because of the shift towards outpatient care and patient preferences for treatment at home. Technological advancements allow patients to manage their IV therapy at home, making it more convenient and cost-effective for managing conditions like dehydration and chronic illnesses.
Regional Insights:
The Southern region has taken the lead in the U.S. Intravenous Solutions Market, attributed to its substantial population, elevated rates of chronic diseases, and comprehensive healthcare infrastructure. The increasing number of elderly individuals in the region, along with a robust network of hospitals and outpatient facilities, contributes to a heightened demand for IV treatments, establishing it as the foremost market for intravenous solutions.
Market Competitive Landscape:
Key players in this market include Grifols USA, LLC, B. Braun Medical Inc, Amphastar Pharmaceuticals, Inc, Athenex, Inc, Fresenius Kabi AG, Pfizer Inc, Baxter, JW Life Science, ICU Medical, Inc, Rockwell Medical, Inc, Exela Pharma Sciences, LLC, among others. Baxter International boasts a diverse product range in renal care, nutrition, respiratory care, hospital beds, and connected care, this is the fifth addition to its collection of Heparin premixed bags.
Recent Developments:
In October 2024, B. Braun Medical revealed its intention to enhance IV saline fluids production by 20% at its facilities located in Irvine, California, and Daytona Beach, Florida. This expansion is expected to increase its annual IV set production by more than 30 million units and will also involve a rise in the manufacturing of related infusion therapy components such as valves and connectors. In February 2024, B. Braun Medical Inc. (B. Braun), a frontrunner in smart infusion therapy and pain management, announced the introduction of its new Heparin Sodium 2,000 units in 0.9% Sodium Chloride Injection, 1,000 mL (2 units/mL), marking the fifth addition to its range of Heparin premixed bags.
In November 2024, Baxter International announced the launch of its initial IV solutions produced at its North Cove facility following the disruptions caused by Hurricane Helene. This facility, responsible for supplying hospital IV fluids and peritoneal dialysis solutions, has successfully resumed 50% of its production levels prior to the hurricane and anticipates complete restoration by the end of the year. Additionally, the company has activated nine plants globally to address supply shortages.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By Nutrients, By End-User |
| Regions covered | Northeast, Midwest, West, South. |
| Companies Covered | Fresenius Kabi AG, Pfizer Inc, Baxter, JW Life Science, ICU Medical, Inc, Grifols USA, LLC, B. Braun Medical Inc, Amphastar Pharmaceuticals, Inc, Athenex, Inc, Rockwell Medical, Inc, Exela Pharma Sciences, LLC. |
- U.S. Intravenous Solutions Market Size (FY 2021-FY 2034)
- Overview of U.S. Intravenous Solutions Market
- Segmentation of U.S. Intravenous Solutions by Product (Total Parenteral Nutrition, Peripheral Parenteral Nutrition)
- Segmentation of U.S. Intravenous Solutions Market by Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids, Parenteral Lipid Emulsion, Others)
- Segmentation of U.S. Intravenous Solutions Market by End-User (Home, Hospitals, Infusion Center)
- Statistical Snap of U.S. Intravenous Solutions Market
- Expansion Analysis of U.S. Intravenous Solutions Market
- Problems and Obstacles in U.S. Intravenous Solutions Market
- Competitive Landscape in the U.S. Intravenous Solutions Market
- Details on Current Investment in U.S. Intravenous Solutions Market
- Competitive Analysis of U.S. Intravenous Solutions Market
- Prominent Players in the U.S. Intravenous Solutions Market
- SWOT Analysis of U.S. Intravenous Solutions Market
- U.S. Intravenous Solutions Market Future Outlook and Projections (FY 2025-FY 2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. U.S. Intravenous Solutions Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U.S. Intravenous Solutions Market
7. U.S. Intravenous Solutions Market, By Product (USD Million) 2021-2034
- 7.1. Total Parenteral Nutrition
- 7.2. Peripheral Parenteral Nutrition
8. U.S. Intravenous Solutions Market, By Nutrients (USD Million) 2021-2034
- 8.1. Carbohydrates
- 8.2. Vitamins & Minerals
- 8.3. Single-dose Amino Acids
- 8.4. Parenteral Lipid Emulsion
- 8.5. Others
9. U.S. Intravenous Solutions Market, By End-User (USD Million) 2021-2034
- 9.1. Home
- 9.2. Hospitals
- 9.3. Infusion Center
10. U.S. Intravenous Solutions Market, (USD Million) 2021-2034
- 10.1. U.S. Intravenous Solutions Market Size and Market Share
11. U.S. Intravenous Solutions Market, By Region (USD Million) 2021-2034
- 11.1. Northeast
- 11.2. Midwest
- 11.3. West
- 11.4. South
12. Company Profile
- 12.1. Fresenius Kabi AG
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. Pfizer Inc
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. Baxter
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. JW Life Science
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. ICU Medical, Inc
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. Grifols USA, LLC
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7.B. Braun Medical Inc
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. Amphastar Pharmaceuticals, Inc
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. Athenex, Inc
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. Rockwell Medical, Inc
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
- 12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
U.S. Intravenous Solutions Market is projected to reach USD 11.39 billion by 2034, growing at a CAGR of of 8.05% during the forecast period.
U.S. Intravenous Solutions Market grew in Market size from 2025. The Market is expected to reach USD 11.39 billion by 2034, at a CAGR of 8.05% during the forecast period.
U.S. Intravenous Solutions Market CAGR of 8.05% during the forecast period.
You can get the sample pages by clicking the link - Click Here
U.S. Intravenous Solutions Market size is USD 11.39 billion from 2025 to 2034.
U.S. Intravenous Solutions Market is covered By Product, By Nutrients, By End-User
The Northeast, Midwest, West, South. is the highest Market share in the U.S. Intravenous Solutions Market.
Fresenius Kabi AG, Pfizer Inc, Baxter, JW Life Science, ICU Medical, Inc, Grifols USA, LLC, B. Braun Medical Inc, Amphastar Pharmaceuticals, Inc, Athenex, Inc, Rockwell Medical, Inc, Exela Pharma Sciences, LLC.
The report includes an in-depth analysis of the U.S. Intravenous Solutions Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
